iSpecimen Acquires Foldlab AI Products for Drug Discovery, Disease Monitoring
iSpecimen says the acquisition expands its business beyond a biospecimen marketplace with agentic AI tools for protein discovery and disease trend prediction.
New Agentic AI tools for protein discovery and disease trend prediction take iSpecimen beyond its biospecimen marketplaceWoburn, Massachusetts--(. - November 5, 2026) - iSpecimen Inc. NASDAQ:ISPC ("iSpecimen" or the "Company"), an online global marketplace connecting scientists who nee…